Latest News

Ora Banda Mining Limited recently reported a challenging December quarter, with gold production falling short of estimates, all-in sustaining costs rising, and FY26 growth capital guidance lifted to A$143,000,000 while production guidance was tightened to the lower end of its target range. Alongside these operational and cost headwinds, the company approved significant new growth projects, including a ~3 Mtpa processing plant study, a new Waihi open pit, and expanded accommodation capacity...

As the U.S. stock market experiences fluctuations driven by mixed corporate earnings and geopolitical uncertainties, investors are increasingly attentive to undervalued opportunities amidst the volatility. In such a climate, identifying stocks that may be trading below their estimated value can offer potential for growth, provided they exhibit strong fundamentals and resilience in challenging conditions.

As the U.S. stock market faces turbulence with major indices like the Dow Jones and S&P 500 experiencing declines, investors are keenly observing companies that exhibit resilience and potential for growth. In such a volatile environment, stocks of growth companies with high insider ownership often stand out as they suggest strong internal confidence in the business's future prospects.

As the U.S. market navigates a landscape marked by fluctuating tech stocks and record highs in precious metals, investors are increasingly looking beyond the well-trodden paths of major indices to uncover potential opportunities in lesser-known small-cap stocks. In this environment, identifying undiscovered gems requires a keen eye for companies with robust fundamentals that can withstand broader market volatility and capitalize on niche growth opportunities.

As the U.S. market faces fluctuations with major indices like the Dow Jones and S&P 500 experiencing declines, investors are increasingly seeking alternative opportunities to diversify their portfolios. Penny stocks, a term that may seem outdated, continue to hold potential for those willing to explore smaller or newer companies that can offer growth at lower price points. With strong balance sheets and solid fundamentals, these stocks can present hidden gems in today's market landscape,...

As the U.S. stock market navigates through a challenging period marked by declining tech shares and fluctuating precious metal prices, investors are increasingly seeking stability amid volatility. In such an environment, dividend stocks can offer a reliable income stream, providing both potential for growth and regular returns that may help cushion against market downturns.

Parex Resources Inc. recently updated its Fiscal Year 2026 average production guidance to 45,000–49,000 boe/d and announced that long-serving Board Chair Wayne Foo will retire in May 2026, with current Vice Chair Glenn McNamara set to assume the Chair role. The combination of refreshed production expectations and a clearly outlined board succession plan highlights how Parex is emphasizing operational clarity and governance continuity for investors. With production guidance now set at...

Elevance Health (ELV) closed out FY 2025 with Q4 revenue of US$49.7b and basic EPS of US$2.47, alongside net income of US$547m. Over the past six quarters, the company has seen quarterly revenue move from US$45.1b in Q3 2024 to a range between US$48.9b and US$50.7b through 2025, while quarterly EPS shifted from US$4.38 to US$9.64 and then to US$2.47. This sets up an earnings print where margin resilience is front of mind for investors. See our full analysis for Elevance Health. With the...

Why the Renergen Helium Project Update Matters for ASP Isotopes (ASPI) ASP Isotopes (ASPI) has given investors a detailed production update on the newly acquired Renergen Helium Project, outlining higher gas throughput, completed plant upgrades, and a timetable toward positive operational cash flow before the end of 2026. See our latest analysis for ASP Isotopes. The Renergen update lands after a volatile stretch, with a 1-day share price return of 1.93% and a 7-day move of 8.77% helping...

Why Vaxart’s Norovirus Data Matters for Investors Vaxart (VXRT) has drawn fresh attention after npj Vaccines published Phase 1 data on its single dose, oral bivalent norovirus vaccine in postpartum, breastfeeding women, highlighting immune responses in both mothers and their infants. See our latest analysis for Vaxart. The new npj Vaccines publication comes after a strong 30 day share price return of 83.38% and 90 day share price return of 81.95%. However, the 1 year total shareholder return...

Greatland Resources Limited recently reported progress on its Telfer Resource Development program, highlighting completion of over 106,000 metres of drilling in the first half of fiscal 2026 and early copper-gold assay results that support its geological models. The company is also targeting a maiden mineral resource estimate for Telfer in the March 2026 quarter, signalling a potential shift from primarily exploration activity toward clearer resource definition. We’ll now examine how the...

Curious whether Broadridge Financial Solutions at around US$204.89 is offering fair value or a potential bargain right now? This article walks through the numbers in a clear way so you can judge for yourself. The stock has seen mixed returns, with a 0.9% decline over the last 7 days, a 9.9% decline over the last 30 days and a 7.1% decline year to date. The 3 year and 5 year returns sit at 40.4% and 54.1% respectively, and the 1 year return is a decline of 11.6%. Recent coverage has focused...

First Busey (BUSE) has put a fuller year of numbers on the table for FY 2025, with fourth quarter revenue of US$197.8 million and EPS of US$0.63, rounding out trailing twelve month revenue of US$666.8 million and EPS of US$1.49. The company has seen revenue move from US$453.7 million and EPS of US$2.01 on a trailing basis in late 2024 to US$666.8 million and EPS of US$1.49 by the end of 2025. This is setting up a results season where investors are weighing those headline figures against a...

Travel + Leisure Co. has opened its new global headquarters at 501 W. Church St. in Downtown Orlando, relocating more than 900 associates and investing over US$36 million in a hybrid-friendly, wellness-focused workplace. The move deepens the company’s ties to Orlando’s urban core while expanding community engagement through the Travel + Leisure Charitable Foundation and local partnerships. We’ll now examine how this Orlando headquarters investment, especially its focus on a modern hybrid...

If you are wondering whether Corteva's current share price still offers value, it helps to step back and look at what the recent numbers and valuation checks are actually saying. Corteva's share price last closed at US$73.05, with returns of 2.2% over 7 days, 8.0% over 30 days, 7.8% year to date, 13.5% over 1 year and 17.2% over 3 years, plus 84.4% over 5 years. This naturally raises questions about how much of this is already reflected in the valuation. Recent news around Corteva has...

If you are wondering whether Icahn Enterprises at a last close of US$7.74 offers genuine value or just headline risk, you are not alone. This article is built to help you weigh that up clearly. The stock has been mixed recently, with a 6.0% return over 30 days and a 3.5% return year to date, set against a 2.4% decline over 1 year and much steeper 3 year and 5 year returns of 73.1% and 67.3% declines. These moves sit in the shadow of earlier scrutiny of Icahn Enterprises' structure and short...

Paladin Energy (ASX:PDN) is back in focus after uranium prices rallied, futures approached $91 a pound and the stock surged. Traders are watching operational metrics and the upcoming interim results closely. See our latest analysis for Paladin Energy. The recent uranium rally and Paladin’s production and cost updates have coincided with strong momentum, with a 30 day share price return of 51.07% and a 1 year total shareholder return of 65.57% reinforcing interest after several years of very...

In recent days, Travere Therapeutics disclosed that the FDA classified additional data for its FILSPARI sNDA as a major amendment, extending the review timeline and setting a new PDUFA action date of April 13, 2026, while multiple law firms announced investigations into potential securities law violations related to the company’s disclosures. This combination of a lengthened regulatory path for a key rare-disease therapy and parallel securities investigations adds an extra layer of...

Houlihan Lokey (NYSE:HLI) has expanded its European footprint with the hire of Mark Ward as Managing Director to lead IT Services coverage. The firm has also completed acquisitions in European real estate and corporate finance, adding sector depth and local capabilities. These moves reflect an active push to grow both organically and through acquisitions in key European markets. At a share price of $180.53, Houlihan Lokey has delivered a 3 year return of 94.8% and a 5 year return of 199.2%...

Frasers Centrepoint Trust reported that its committed occupancy rose to 99.9% in the first quarter ended December 2025, helped by backfilling former cinema spaces at Century Square and Causeway Point after the prior operator’s liquidation. By swiftly re-leasing these large, previously vacant entertainment spaces, the manager underscored its asset-management capabilities and potential to stabilise rental income streams. We will now explore how this near-full occupancy, especially the...

In January 2026, First Horizon Corporation raised its quarterly common dividend to US$0.17 per share and declared regular cash dividends on several preferred stock series, with payments scheduled in April and May 2026 to shareholders of record in March and April. The combination of higher common payouts and continued preferred dividends highlights management’s confidence in the bank’s earnings capacity following stronger fourth-quarter 2025 results. We’ll now examine how the higher common...

NovaGold Resources (TSX:NG) announced a $200 million private placement. The financing includes significant participation from a leading European institution. The transaction is expected to influence the company’s funding profile and potential project development plans. NovaGold Resources, which focuses on gold development, is drawing attention with this $200 million capital raise that includes a major European investor. For shareholders or potential investors, the size of the deal and the...

Christian Dior (ENXTPA:CDI) opened FY 2025 with first half revenue of €39.8b and basic EPS of €13.14, alongside net income of €2,371m, setting a clear earnings-season marker for investors tracking the luxury group. The company has seen recent half year revenue move from €41.7b and EPS of €16.76 in H1 2024 to €43.0b and EPS of €12.11 in H2 2024, with trailing 12 month EPS sitting in the mid €20s, while net profit margin for the latest trailing year came in at 5.6% versus 6.2% a year earlier...

If you are wondering whether Andean Precious Metals is already priced for perfection or still offers value, the starting point is to look closely at what the current market price might be implying. The share price recently closed at CA$10.40, with returns of 2.0% over the last 7 days, a small 0.3% decline over 30 days, a 7.2% gain year to date, and a very large increase over the past year and past three years. Recent share price moves have come alongside ongoing investor interest in precious...